Heart in Diabetes

The latest news from HiD, with physician perspective, interviews and clinician insight on cardiometabolic health.

Meeting News

Top takeaways from Heart in Diabetes 2019

July 28, 2019
Endocrine Today has compiled a list of the top five news reports posted from Heart in Diabetes, held July 12-14, 2019, in Philadelphia…
Meeting News

Treatment of HFpEF in type 2 diabetes critical in improving outcomes

July 25, 2019
PHILADELPHIA — Ways to effectively manage and diagnose HF with reduced ejection fraction in patients with type 2 diabetes have become a point…
Meeting NewsPerspective

Once-weekly exenatide reduces MACE risk in patients with type 2 diabetes, CVD

July 18, 2019
PHILADELPHIA — Among patients with type 2 diabetes and confirmed CVD at baseline, treatment with once-weekly exenatide reduced the risk for…
Meeting NewsVideo

VIDEO: Heart in Diabetes aims to address ‘avalanche of data’ on diabetes, CVD

July 16, 2019
PHILADELPHIA — In this video exclusive, Mikhail N. Kosiborod, MD, FACC, FAHA, co-chair of the third annual Heart in Diabetes conference…
Meeting NewsPerspective

Weight loss mediates CV damage of fatty liver in diabetes

July 16, 2019
PHILADELPHIA — Nonalcoholic fatty liver disease is an “unrecognized epidemic” among people with type 2 diabetes, according to a…
Meeting News

Multitude of treatment options puts drastically reduced LDL cholesterol within reach

July 16, 2019
PHILADELPHIA —LDL cholesterol can be reduced to even more beneficial levels than ever before by use of a number of medications, including PCSK9…
Meeting News

Trial data highlight need for redefined guidelines for older adults with diabetes

July 15, 2019
PHILADELPHIA — Older adults with type 2 diabetes can derive meaningful cardiovascular and renal benefits from newer antihyperglycemic agents…
Meeting News

Ethnicity, age, sex influence CV risk in type 2 diabetes

July 15, 2019
PHILADELPHIA — The growing global burden of type 2 diabetes and cardiovascular disease disproportionately affects people living in countries…
Meeting News

Addition of ezetimibe to statin yields greatest CV benefit in patients with diabetes and high-risk diabetics

July 14, 2019
PHILADELPHIA — In a subgroup analysis of the IMPROVE-IT trial, which included patients with recent ACS on statin therapy, those with diabetes…
Meeting NewsVideo

VIDEO: SGLT-2 inhibitors provide positive cardiorenal outcomes

July 14, 2019
PHILADELPHIA — In this video exclusive, Mark E. Cooper, AO, PhD, head of the department of diabetes at Monash University in Melbourne…

Meeting Calendar

Heart in Diabetes

June 26, 2020 - June 28, 2020